In general, our results reveal an upregulation in the concentration of plasma TNF-α, IL-2, IL-6, and IL-8 levels in MDS patients, reflecting an alteration of the inflammatory signaling. The gene discussed is CXCL8; the disease is myelodysplastic syndrome.